Hyperplastic polyposis and cancer of the colon with gastrinoma of the duodenum

Nature Clinical Practice Oncology

Volumn 3, Issue 5, 2006, Pages 281-284

  Goswami, Rashmi S ^a   Minoo, Parham ^a   Baker, Kristi ^a   Chong, George ^a,b   Foulkes, William D ^a   Jass, Jeremy R ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Adenoma; Colored cancer; Gastrinoma; Hyperplastic polyposis; Zollinger Ellison syndrome

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GASTRIN;

ABDOMINAL CRAMP; ABDOMINAL RADIOGRAPHY; ADULT; ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CECUM CARCINOMA; CLINICAL FEATURE; COLON CANCER; COLON POLYPOSIS; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DUODENUM TUMOR; FEMALE; GASTRIN BLOOD LEVEL; GASTRINOMA; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; ILEORECTAL ANASTOMOSIS; PHYSICAL EXAMINATION; POLYPECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLECTOMY; COLONIC NEOPLASMS; COLONIC POLYPS; DIAGNOSIS, DIFFERENTIAL; DUODENAL NEOPLASMS; FEMALE; GASTRINOMA; HUMANS; HYPERPLASIA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; TREATMENT OUTCOME; ZOLLINGER-ELLISON SYNDROME;

EID: 33646693823     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0482     Document Type: Article

References (19)

1. Jensen RT (2004) Gastrinomas: Advances in diagnosis and management. Neuroendocrinology 80 (Suppl 1): S23-S27
2. Gibril F et al. (2004) Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: A prospective study of 107 cases and comparison with 1,009 cases from the literature. Medicine (Baltimore) 83: 43-83
3. Jass JR (2005) Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2: 398-405
4. Torlakovic et al. (2003) Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27: 65-81
5. Jass JR (2000) Familial colorectal cancer: Pathology and molecular characteristics. Lancet Oncol 1: 220-226
6. Min-/+ mouse model of familial adenomatous polyposis. Cancer Res. 61: 625-631
7. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
8. Baldwin GS and Shulkes A (1998) Gastrin, gastrin receptors and colorectal cancer. Gut 42: 581-584
9. Tarasova NI et al. (1997) Endocytosis of gastrin in cancer cells expressing gastrin/CCK-B receptor. Cell Tissue Res 287: 325-333
10. Seva C et al. (1996) Gastrin induces tyrosine phosphorylation of Shc proteins and their association with the Grb2/Sos complex. FEBS Lett 378: 74-78
11. Todisco A et al. (1997) Molecular mechanisms for the growth factor action of gastrin. Am J Physiol 273: G891-G898
12. Miyazaki Y et al. (1999) Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor. Gastroenterology 116: 78-89
13. Fukui H et al. (1998) Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology 115: 1483-1493
14. Rengifo-Cam W and Singh P (2004) Role of progastrins and gastrins and their receptors in GI and pancreatic cancers: Targets for treatment. Curr Pharm Des 10: 2345-2358
15. House MG et al. (2003) Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg 238: 423-431
16. Hyman NH et al. (2004) Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 47: 2101-2104
17. Ferrandez A et al. (2004) Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: Case series and literature review. Am J Gastroenterol 99: 2012-2018
18. Lage P et al. (2004) Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: A contribution for future guidelines based on a clinical study. Am J Gastroenterol 99: 1779-1784
19. Popat S et al. (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618